Boston Scientific Corp. (NYSE:BSX) sued Cook Group, a slew of its subsidiaries and a group of Korean firms, alleging infringement of four endoscopic stent patents covering devices to treat the digestive system.
The lawsuit, filed in the U.S. District Court for Massachusetts, accuses Warsaw, Indiana-based Cook and the subsidiaries (including Cook Ireland Ltd.) of violating the quartet of patents with its Evolution stenting system, according to court documents.
The suit also accuses Korean firms Taewong Medical Co. Ltd., Standard Sci-Tech Inc. and Sewoon Medical Co. Inc., along with Alpharetta, Ga.-based EndoChoice Inc., of violating three of the patents. Taewong’s Niti-S system and Standard Sci-Tech’s Bonastent system are named in the suit.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The lawsuit seeks a jury trial, declarations of infringement, injunctions barring any further infringement, damages, pre- and post-judgment interest and legal fees.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
